<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>International Gemological Institute Ltd. (IGIL) — Tipsheet</title>
    <link>https://tipsheet.markets/company/igil/</link>
    <atom:link href="https://tipsheet.markets/company/igil/feed.xml" rel="self" type="application/rss+xml" />
    <description>Every Tipsheet Editorial note covering International Gemological Institute Ltd. (IGIL), newest first. Grounded in BSE/NSE primary-source filings.</description>
    <language>en-in</language>
    <lastBuildDate>Mon, 06 Jul 2026 10:22:47 GMT</lastBuildDate>
    <item>
      <title>IGIL targets 20% EBITDA growth in FY27 as LGD expansion, AGL integration take shape</title>
      <link>https://tipsheet.markets/igil-igil-targets-20-ebitda-growth-in-fy27-as-lgd-expansion-agl-integration-take-shape-93358/</link>
      <guid isPermaLink="true">https://tipsheet.markets/igil-igil-targets-20-ebitda-growth-in-fy27-as-lgd-expansion-agl-integration-take-shape-93358/</guid>
      <pubDate>Wed, 20 May 2026 18:39:59 GMT</pubDate>
      <description>Management guided 15% revenue and 20% EBITDA growth for FY27, with clarity on lab-grown diamond capacity and the AGL acquisition synergy timeline.</description>
      <content:encoded><![CDATA[<p><em>Management guided 15% revenue and 20% EBITDA growth for FY27, with clarity on lab-grown diamond capacity and the AGL acquisition synergy timeline.</em></p>
<h3>What’s new</h3><ul><li>FY27 guidance: 15% revenue, 20% EBITDA growth</li><li>LGD capacity expansion plans detailed in concall</li><li>AGL acquisition integration progress and expected synergies</li></ul>
<h3>Why it matters</h3><p>Mid-cap gems &amp; jewellery firms rarely give explicit annual guidance. IGIL's 15/20 target signals confidence in LGD and AGL-led growth, but execution risk remains high in a volatile diamond market.</p>
<h3>What we’re watching</h3><ul><li>Monthly LGD certification volumes — early indicator of demand</li><li>AGL's revenue contribution in H1FY27</li><li>Any deviation from the 20% EBITDA margin trajectory</li></ul>
<h3>The full read</h3><p>IGIL's concall did more than recap results — it laid out a two-year roadmap. Management guided 15% revenue and 20% EBITDA growth for FY27, backed by a lab-grown diamond (LGD) capacity expansion that will double certification throughput by Q3FY27. The AGL acquisition, closed last quarter, is on track to add ₹35 cr in annual revenue from FY27 onwards, with cross-sell synergies emerging in the US. The guidance is rare for this mid-cap — most peers offer only qualitative outlook. While the targets are achievable if end-consumer demand holds, the diamond industry is notorious for supply-chain volatility. IGIL is betting that LGD certification becomes a recurring, higher-margin business and that AGL's US presence opens a wider moat. The next two quarters will test whether the execution matches the ambition.</p>
<p>Primary source: <a href="https://www.bseindia.com/corporates/ann.html?scrip=544311&dur=A">BSE</a> · <a href="https://www.nseindia.com/companies-listing/corporate-filings-announcements?symbol=IGIL">NSE</a></p>]]></content:encoded>
      <category>Concalls</category>
      <dc:creator>Tipsheet Editorial</dc:creator>
    </item>
  </channel>
</rss>